Pharmacogenomic (PGx) Testing Market

Pharmacogenomic (PGx) Testing Market By Test Type (Therapeutic Tests, Diagnostic Tests), By Application (Oncology, Cardiovascular), By End User (Diagnostic Laboratories, Research Laboratories, Academic Research Institutes) & By Region - Global Market Insights 2018 To 2028

Analysis of Pharmacogenomic (PGx) Testing market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Free Sample

Introduction

Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism of the medication varies significantly. One drug that works efficiently may not work for the other person due to variation in the time for metabolism.

For example, prodrugs administered are required to be converted into the active form for the therapeutic effect whereas if the metabolism rate is too slow then amount of the prodrug converted to active form may be very less hampering the desired bioavailability of actual active drug which in turn may not work. Whereas, if the metabolism is too fast for the prodrug then too much of active drug can result in the hyperactivity.

Pharmacogenomic (PGx) Testing Market: Drivers and Restraints

Increasing use of the patient specific treatment expected to drive the growth of the pharmacogenomic (PGx) testing market. The increasing emphasis of healthcare professionals to minimize sever adverse reactions of medication which varies person to person tremendously further expected to drive the growth of the pharmacogenomic (PGx) testing market. The growing patient specific approach for the treatment of chronic diseases and study of factors which can impact treatment such as genetic factors which may influence the desired action of medication further expected to fuel the growth of pharmacogenomic (PGx) testing market.

The genetic make-up is unique for each person and it doesn’t change hence pharmacogenomic (PGx) testing helps in choosing the patient specific treatment option driving the growth of the market. Pharmacogenomic (PGx) testing enables physicians to choose better suited treatment for the particular patient in turn helping to attain better therapeutic effect driving the growth of the pharmacogenomic (PGx) testing market. Whereas, low awareness among the general population and healthcare professionals may hamper the potential growth of the market.

Pharmacogenomic (PGx) Testing Market: Overview

The increasing episodes of the adverse reactions in patients forcing healthcare professionals as well as manufacturers to alter the traditional treatment method, which is one of the major factor driving the growth of pharmacogenomic (PGx) testing market. By test type, diagnostic tests expected to dominate the global market. Whereas, by application pharmacogenomic (PGx) testing market is expected to be dominated by the oncology segment due to higher reports of life threatening adverse reactions in the cancer patients.

By end user the global pharmacogenomic (PGx) testing market is expected to be dominated by the diagnostic laboratories due to higher patient footfall for the test. The manufacturers in the global pharmacogenomic (PGx) testing market are focusing on the research and development activity.

Pharmacogenomic (PGx) Testing Market: Regional Outlook

The global pharmacogenomic (PGx) testing market is dominated by the North America due to availability of high end products for the pharmacogenomic (PGx) testing. Europe is expected to be second most lucrative pharmacogenomic (PGx) testing market in due to higher reports of adverse reactions and for the prevention more physicians are preferring use of pharmacogenomic (PGx) testing. Asia-Pacific is the emerging market due to increasing awareness about the availability of such pharmacogenomic (PGx) testing to minimize adverse events.

Latin America pharmacogenomic (PGx) testing market is expected to experience gradual growth whereas Middle East and Africa is expected to be least lucrative pharmacogenomic (PGx) testing market due to low product penetration in the most part of the region.

Pharmacogenomic (PGx) Testing Market: Key Players

The key market players operating in the pharmacogenomic (PGx) testing market are: Affymetrix, Inc., Becton Dickinson and Company, Bayer AG, Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., AstraZeneca PLC, QIAGEN and others.

The research report presents a comprehensive assessment of the Pharmacogenomic (PGx) Testing market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Pharmacogenomic (PGx) Testing market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Pharmacogenomic (PGx) Testing Market Segments
Pharmacogenomic (PGx) Testing Market Dynamics
Pharmacogenomic (PGx) Testing Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Indication
Value Chain

Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Pharmacogenomic (PGx) Testing Market: Segmentation

The global pharmacogenomic (PGx) testing market is segmented based on the by test type, application, end user and region

By test type pharmacogenomic (PGx) testing market is segmented as:

Therapeutic Tests
Diagnostic Tests

By application, the global pharmacogenomic (PGx) testing market is segmented as:

Oncology
Cardiovascular
Others

By end user, global pharmacogenomic (PGx) testing market is segmented as:

Diagnostic Laboratories
Research Laboratories
Academic Research Institutes

Table of Content

Executive Summary - Pharmacogenomic (PGx) Testing Market
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Inclusion and Exclusion
Value Added Insights
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
  - Supply Side Participants and their Roles
    - Producers
    - Mid-Level Participants (Traders/ Agents/ Brokers)
    - Wholesalers and Distributors
  - Value Added and Value Created at Node in the Supply Chain
  - List of Raw Material Suppliers
  - List of Existing and Potential Buyers
- Pricing Analysis of Pharmacogenomic (PGx) Testing Market
  - Pricing Analysis By Region
  - Pricing Analysis By Country
  - Pricing Analysis By End Use
  - Pricing Analysis By Distributor
  - Pricing Analysis By Application
- Value Chain Analysis
  - Profit Margin Analysis
  - Wholesalers and Distributors
  - Retailers
- Product Portfolio Analysis
- Regulatory Landscape
  - By Key Regions
  - By Key Countries
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Investment Feasibility Matrix
- PESTLE Analysis
  - Political Factors
    - Government stability and change
    - Taxation policy and incentives
    - Trade tariffs and import/export regulations
    - Political risk and corruption levels
  - Economic Factors
    - GDP growth and economic cycles
    - Inflation and interest rates
    - Exchange rate fluctuations
    - Unemployment and consumer spending power
  - Social Factors
    - Demographic trends (age, population growth)
    - Cultural attitudes and lifestyle changes
    - Education levels and workforce skills
    - Health consciousness and social values
  - Technological Factors
    - Rate of technological innovation
    - R&D activity and automation trends
    - Digital infrastructure and connectivity
    - Intellectual property protection
  - Legal Factors
    - Employment and labor laws
    - Health & safety regulations
    - Consumer protection laws
    - Data privacy and antitrust legislation
  - Environmental Factors
    - Environmental regulations and compliance
    - Climate change impacts and carbon footprint
    - Resource availability and sustainability practices
    - Waste management and recycling initiatives
- Market Background and Dynamics
  - Market Dynamics
    - Drivers
    - Restraints
    - Opportunity
    - Trends
  - SWOT Analysis of Global Pharmacogenomic (PGx) Testing Market
    - Strengths
    - Weaknesses
    - Opportunities
    - Threats
Global Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast, 2025-2035
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Projections, 2025-2035
  - Y-o-Y Growth Trend Analysis
  - Absolute $ Opportunity Analysis
- Revenue Forecast Scenario, 2020-2035
  - Conservative Scenario
  - Likely Scenario
  - Optimistic Scenario
Global Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Application, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Application, 2025-2035
- Y-o-Y Growth Trend Analysis By Application, 2020-2024
- Absolute $ Opportunity Analysis By Application, 2025-2035
- Market Attractiveness Analysis By Application, 2025-2035
Global Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By End Use
- Introduction / Key Findings
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By End Use, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By End Use, 2025-2035
- Y-o-Y Growth Trend Analysis By End Use, 2020-2024
- Absolute $ Opportunity Analysis By End Use, 2025-2035
- Market Attractiveness Analysis By End Use, 2025-2035
Global Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Region
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Analysis By Region, 2020-2024
- Current Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Region, 2025-2035
  - North America
  - Latin America
  - Western Europe
  - Eastern Europe
  - East Asia
  - South Asia and Pacific & Pacific
  - MEA
- Market Attractiveness Analysis By Region
North America Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035
- Introduction
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Current and Future Market Size Value (USD Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2025-2035
- By Country
  - USA
  - Canada
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - USA Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Canada Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Mexico Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Latin America Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Brazil
  - Argentina
  - Chile
  - Rest of Latin America
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Brazil Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Argentina Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Chile Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Latin America Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Western Europe Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Germany
  - UK
  - Italy
  - Spain
  - France
  - Nordic
  - BENELUX
  - Rest of Western Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Germany Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - UK Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Italy Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Spain Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - France Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Nordic Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - BENELUX Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Western Europe Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Eastern Europe Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Russia
  - Poland
  - Hungary
  - Balkan & Baltic
  - Rest of Eastern Europe
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Russia Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Poland Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Hungary Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Balkan & Baltic Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of Eastern Europe Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
East Asia Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - China
  - Japan
  - South Korea
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - China Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Japan Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Korea Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
South Asia and Pacific Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - India
  - ASEAN
  - Australia & New Zealand
  - Rest of South Asia and Pacific
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - India Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - ASEAN Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Australia & New Zealand Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of South Asia and Pacific Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
MEA Pharmacogenomic (PGx) Testing Market Analysis 2020-2024 and Forecast 2025-2035, By Country
- Historical Market Size Value (USD Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2020-2024
- Market Size Value (USD Mn) & Volume (Units) Forecast By Market Taxonomy, 2025-2035
- By Country
  - Kingdom of Saudi Arabia
  - Other GCC Countries
  - Turkiye
  - South Africa
  - Other African Union
  - Rest of Middle East & Africa
- By Application
- By End Use
- Market Attractiveness Analysis
  - By Country
  - By Application
  - By End Use
- Key Takeaways
- Market Trends
- Key Market Participants - Intensity Mapping
- Drivers and Restraints - Impact Analysis
- Country Level Analysis & Forecast
  - Kingdom of Saudi Arabia Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Other GCC Countries Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Turkiye Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - South Africa Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
  - Rest of MEA Pharmacogenomic (PGx) Testing Market
    - Introduction
    - Market Analysis and Forecast by Market Taxonomy
    - By Application
    - By End Use
Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
  - By Region
  - By Application
  - By End Use
- Competition Analysis
- Competition Deep Dive
  - Global Key Players
  - Key Players by Region
  - Key Players by Country
Assumptions & Acronyms Used
Research Methodology

List Of Table

Table 1: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Region, 2020-2035
Table 2: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Region, 2020-2035
Table 3: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 4: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 5: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 6: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 7: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 8: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 9: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 10: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 11: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 12: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 13: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 14: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 15: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 16: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 17: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 18: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 19: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 20: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 21: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 22: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 23: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 24: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 25: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 26: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 27: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 28: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 29: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 30: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 31: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 32: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 33: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 34: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 35: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 36: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 37: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 38: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 39: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 40: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 41: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 42: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035
Table 43: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Country, 2020-2035
Table 44: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Country, 2020-2035
Table 45: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by Application, 2020-2035
Table 46: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by Application, 2020-2035
Table 47: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Forecast by End Use, 2020-2035
Table 48: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Forecast by End Use, 2020-2035

List Of Figures

Figure 1: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 2: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 3: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Region, 2020-2035
Figure 4: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Region, 2020-2035
Figure 5: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Region, 2020-2035
Figure 6: Global Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Region, 2020-2035
Figure 7: Global Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Region, 2020-2035
Figure 8: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 9: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 10: Global Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 11: Global Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 12: Global Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 13: Global Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 14: Global Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 15: Global Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 16: Global Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 17: Global Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 18: Global Pharmacogenomic (PGx) Testing Market Attractiveness by Region, 2020-2035
Figure 19: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 20: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 21: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 22: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 23: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 24: North America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 25: North America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 26: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 27: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 28: North America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 29: North America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 30: North America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 31: North America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 32: North America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 33: North America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 34: North America Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 35: North America Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 36: North America Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 37: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 38: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 39: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 40: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 41: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 42: Latin America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 43: Latin America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 44: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 45: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 46: Latin America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 47: Latin America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 48: Latin America Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 49: Latin America Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 50: Latin America Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 51: Latin America Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 52: Latin America Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 53: Latin America Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 54: Latin America Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 55: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 56: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 57: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 58: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 59: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 60: Europe Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 61: Europe Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 62: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 63: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 64: Europe Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 65: Europe Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 66: Europe Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 67: Europe Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 68: Europe Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 69: Europe Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 70: Europe Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 71: Europe Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 72: Europe Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 73: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 74: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 75: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 76: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 77: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 78: East Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 79: East Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 80: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 81: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 82: East Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 83: East Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 84: East Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 85: East Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 86: East Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 87: East Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 88: East Asia Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 89: East Asia Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 90: East Asia Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 91: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 92: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 93: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 94: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 95: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 96: South Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 97: South Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 98: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 99: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 100: South Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 101: South Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 102: South Asia Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 103: South Asia Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 104: South Asia Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 105: South Asia Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 106: South Asia Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 107: South Asia Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 108: South Asia Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 109: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 110: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 111: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 112: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 113: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 114: Oceania Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 115: Oceania Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 116: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 117: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 118: Oceania Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 119: Oceania Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 120: Oceania Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 121: Oceania Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 122: Oceania Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 123: Oceania Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 124: Oceania Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 125: Oceania Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 126: Oceania Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035
Figure 127: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Application, 2020-2035
Figure 128: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by End Use, 2020-2035
Figure 129: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) by Country, 2020-2035
Figure 130: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Country, 2020-2035
Figure 131: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Country, 2020-2035
Figure 132: MEA Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Country, 2020-2035
Figure 133: MEA Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Country, 2020-2035
Figure 134: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by Application, 2020-2035
Figure 135: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by Application, 2020-2035
Figure 136: MEA Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by Application, 2020-2035
Figure 137: MEA Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by Application, 2020-2035
Figure 138: MEA Pharmacogenomic (PGx) Testing Market Value (US$ Mn) Analysis by End Use, 2020-2035
Figure 139: MEA Pharmacogenomic (PGx) Testing Market Volume (Units) Analysis by End Use, 2020-2035
Figure 140: MEA Pharmacogenomic (PGx) Testing Market Value Share (%) and BPS Analysis by End Use, 2020-2035
Figure 141: MEA Pharmacogenomic (PGx) Testing Market Y-o-Y Growth (%) Projections by End Use, 2020-2035
Figure 142: MEA Pharmacogenomic (PGx) Testing Market Attractiveness by Application, 2020-2035
Figure 143: MEA Pharmacogenomic (PGx) Testing Market Attractiveness by End Use, 2020-2035
Figure 144: MEA Pharmacogenomic (PGx) Testing Market Attractiveness by Country, 2020-2035

- FAQs -

How is the pharmacogenomic (PGx) testing market predicted to advance?

Demand for pharmacogenomic (PGx) testing is slated to rise at an 8% CAGR through 2028.

Which factors favour pharmacogenomic (PGx) testing market evolution?

Rising investments in research & development and a growing focus on healthcare are two prominent drivers for the market.

Why is North America a lucrative market for pharmacogenomic testing?

The presence of developed healthcare infrastructure and availability of high-end pharmacogenomic testing products make North America a bankable market.

Pharmacogenomic (PGx) Testing Market

Schedule a Call